Cargando…

The Impact of the Ongoing COVID-19 Epidemic on the Increasing Risk of Adverse Pathology in Prostate Cancer Patients Undergoing Radical Prostatectomy

We aimed to assess whether the ongoing course of the COVID-19 epidemic has been associated with an increased risk of adverse pathology (AP) findings in prostate cancer (PC) patients treated with radical prostatectomy (RP). We performed a retrospective data analysis which included 408 consecutive, no...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nyk, Łukasz, Kamecki, Hubert, Zagożdżon, Bartłomiej, Tokarczyk, Andrzej, Baranek, Piotr, Mielczarek, Łukasz, Kryst, Piotr, Poletajew, Sławomir, Sosnowski, Roman, Szempliński, Stanisław
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027555/ https://www.ncbi.nlm.nih.gov/pubmed/35448199 http://dx.doi.org/10.3390/curroncol29040225

Ejemplares similares

High-Intensity Focused-Ultrasound Focal Therapy Versus Laparoscopic Radical Prostatectomy: A Comparison of Oncological and Functional Outcomes in Low- and Intermediate-Risk Prostate Cancer Patients
por: Nyk, Łukasz, et al.
Publicado: (2022)

Predictors of Clinically Significant Prostate Cancer in Patients with PIRADS Categories 3–5 Undergoing Magnetic Resonance Imaging-Ultrasound Fusion Biopsy of the Prostate
por: Szempliński, Stanisław, et al.
Publicado: (2022)

Patient-reported pain associated with grid-based transperineal magnetic resonance imaging (MRI)/ultrasound (US) software fusion biopsy of the prostate under local anesthesia: a multicenter experience
por: Szempliński, Stanisław, et al.
Publicado: (2023)

Quantification of Gleason Pattern 4 at MRI-Guided Biopsy to Predict Adverse Pathology at Radical Prostatectomy in Intermediate-Risk Prostate Cancer Patients
por: Kamecki, Hubert, et al.
Publicado: (2023)

Diagnostic Performance of Preoperative Choline-PET/CT in Patients Undergoing Salvage Lymph Node Dissection for Recurrent Prostate Cancer: A Multicenter Experience
por: Nyk, Łukasz, et al.
Publicado: (2022)

Prostate Biopsy in the Case of PIRADS 5—Is Systematic Biopsy Mandatory?
por: Malewski, Wojciech, et al.
Publicado: (2023)

The role of mpMRI in qualification of patients with ISUP 1 prostate cancer on biopsy to radical prostatectomy
por: Nyk, Łukasz, et al.
Publicado: (2021)

Multi-Drug Resistant Bacteria as Aetiological Factors of Infections in a Tertiary Multidisciplinary Hospital in Poland
por: Poletajew, Sławomir, et al.
Publicado: (2021)

Clinical significance of surgical margin status in patients subjected to radical prostatectomy
por: Dobruch, Jakub, et al.
Publicado: (2012)

Pushing the boundaries: emerging role of radical prostatectomy as part of multimodal treatment for oligometastatic prostate cancer
por: Sosnowski, Roman, et al.
Publicado: (2023)

Should all specimens taken during surgical treatment of patients with benign prostatic hyperplasia be assessed by a pathologist?
por: Skrzypczyk, Michał Andrzej, et al.
Publicado: (2014)

Blood loss during laparoscopic radical prostatectomy – is it significant or not?
por: Poletajew, Sławomir, et al.
Publicado: (2012)

Behind a personalized therapy with immune check-point inhibitors in metastatic bladder cancer: ready for a primetime?
por: Poletajew, Sławomir, et al.
Publicado: (2020)

Incidental Diagnosis of Urothelial Bladder Cancer: Associations with Overall Survival
por: Kamecki, Hubert, et al.
Publicado: (2023)

Non-Invasive Biomarkers in the Diagnosis of Upper Urinary Tract Urothelial Carcinoma—A Systematic Review
por: Białek, Łukasz, et al.
Publicado: (2022)

The Clinical Utility of Systemic Immune-Inflammation Index Supporting Charlson Comorbidity Index and CAPRA-S Score in Determining Survival after Radical Prostatectomy—A Single Centre Study
por: Zapała, Piotr, et al.
Publicado: (2022)

Laparoscopic radical prostatectomy and extended pelvic lymph node dissection: a combined technique
por: Jarzemski, Piotr, et al.
Publicado: (2020)

Bladder perforation during transurethral resection of bladder tumour is not a result of a deficient structure of the bladder wall
por: Poletajew, Sławomir, et al.
Publicado: (2020)

TGF-β and microRNA Interplay in Genitourinary Cancers
por: Boguslawska, Joanna, et al.
Publicado: (2019)

En-bloc resection of urinary bladder tumour – a prospective controlled multicentre observational study
por: Poletajew, Sławomir, et al.
Publicado: (2020)

Human kidney injury molecule-1 as a urine biomarker differentiating urothelial and renal cell carcinoma
por: Białek, Łukasz, et al.
Publicado: (2021)

Diagnostic and treatment delays among patients with primary bladder cancer in Poland: a survey study
por: Mielczarek, Łukasz, et al.
Publicado: (2020)

Active surveillance for low-risk prostate cancer: well established, yet avoided?
por: Sosnowski, Roman, et al.
Publicado: (2022)

piRNAs and PIWI Proteins as Diagnostic and Prognostic Markers of Genitourinary Cancers
por: Hanusek, Karolina, et al.
Publicado: (2022)

Prostate Imaging Reporting and Data System in prostate cancer staging and planning for radical prostatectomy
por: Kozikowski, Mieszko, et al.
Publicado: (2019)

Clinical rationale and safety of restaging transurethral resection in indication-stratified patients with high-risk non-muscle-invasive bladder cancer
por: Zapała, Piotr, et al.
Publicado: (2018)

Role of preoperative patient education among prostate cancer patients treated by radical prostatectomy
por: Jurys, Tomasz, et al.
Publicado: (2022)

Maintaining plasma quality and safety in the state of ongoing epidemic – The role of pathogen reduction
por: Wasiluk, Tomasz, et al.
Publicado: (2021)

3.0-T multiparametric magnetic resonance imaging modifies the template of endoscopic, conventional radical prostatectomy in all cancer risk categories 
por: Kozikowski, Mieszko, et al.
Publicado: (2018)

Magnetic resonance imaging (MRI) for local staging before salvage radical prostatectomy: a meta-analysis
por: Zapała, Piotr, et al.
Publicado: (2023)

PSA mass as a marker of prostate cancer progression after radical prostatectomy
por: Bryniarski, Piotr, et al.
Publicado: (2011)

Urinary incontinence after radical prostatectomy – experience of the last 100 cases
por: Sosnowski, Roman, et al.
Publicado: (2011)

E-Cadherin, Integrin Alpha2 (Cd49b), and Transferrin Receptor-1 (Tfr1) Are Promising Immunohistochemical Markers of Selected Adverse Pathological Features in Patients Treated with Radical Prostatectomy
por: Zapała, Piotr, et al.
Publicado: (2021)

Surgical treatment for renal masses in the elderly: analysis of oncological, surgical and functional outcomes
por: Poletajew, Slawomir, et al.
Publicado: (2019)

Macroscopic Hematuria—A Leading Urological Problem in Patients on Anticoagulant Therapy: Is the Common Diagnostic Standard Still Advisable?
por: Antoniewicz, Artur A., et al.
Publicado: (2012)

Epstein-Barr Virus and Human Adenovirus Viremia in Renal Tumors Is Associated with Histological Features of Malignancy
por: Kryst, Piotr, et al.
Publicado: (2020)

The time from diagnosis of bladder cancer to radical cystectomy in Polish urological centres – results of CysTiming Poland study
por: Poletajew, Sławomir, et al.
Publicado: (2014)

Preservation of continence in radical prostatectomy patients: a laparoscopic surgeon’s perspective
por: Kania, Piotr, et al.
Publicado: (2019)

Endoscopic extraperitoneal radical prostatectomy: An initial report following the first 30 cases
por: Jakóbczyk, Bartłomiej, et al.
Publicado: (2017)

Renal carcinoma infiltrating inferior vena cava and combined valvular heart disease - one-stage uro-cardiological procedure: a case report
por: Antoniewicz, Artur A, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_d56b6uueob0186njkcjnntm799